vimarsana.com

Latest Breaking News On - Adam gridley - Page 1 : vimarsana.com

Allay Therapeutics' Phase 2B Clinical Study Supports Ability of ATX101 To Deliver Four Weeks of Sustained Post-surgical Pain Relief

Allay Therapeutics' Phase 2B Clinical Study Supports Ability of ATX101 To Deliver Four Weeks of Sustained Post-surgical Pain Relief
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
Singapore
Australia
Canada
United-states
Chris-railey
David-hewitt
Hemant-pandit
Adam-gridley
University-of-leeds
Lightstone-venture-singapore-fund
Drug-administration

Allay Therapeutics Announces Development and Commercialization Agreement with Maruishi Pharmaceutica

SAN JOSE, Calif. & OSAKA, Japan (BUSINESS WIRE) Allay Therapeutics, Inc. (Allay) today announced that they have entered into a license agreement with Maruishi Pharmaceutical Co., Ltd. (Maruishi), providing Maruishi with exclusive rights to develop and commercialize Allay’s lead investigational drug candidate, ATX1.

Japan
Osaka
Singapore
Japanese
Katsuhito-inoue
Adam-gridley
Maruishi-pharmaceutical-co-ltd
Therapeutics-inc
Allay-therapeutics
Chief-executive-officer
Representative-director

Allay grants pain management drug license to Japan's Maruishi

Allay Therapeutics has announced a licensing agreement granting Maruishi Pharmaceutical exclusive rights to develop and commercialise ATX101 in Japan.

Japan
Japanese
Adam-gridley
Katsuhito-inoue

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.